Shuohui Dong et al. discovered that CRC resistance to 5-FU is caused by AKT signaling, which is activated nonoxygen-dependently by reactive oxygen species.48 Ye Zhang et al. discovered that the resistance of CRC to oxaliplatin can be reversed through inhibition of the AKT pathway. The gene discussed is AKT1; the disease is colorectal carcinoma.